Mounjaro®
Starting from £179.99/mo
Start journey Learn moreStopping Wegovy is a straightforward physical process — you simply don't inject the next dose — but quitting without a plan significantly increases the chance of regaining the weight you lost. Semaglutide leaves your system gradually over several weeks, so the effects don't vanish overnight, yet what happens next depends heavily on what you put in place before that last pen runs out. Whether your reason is cost, side effects, pregnancy planning, surgery, or simply feeling you've reached your goal, the guidance below covers what the clinical evidence actually says and what to discuss with your prescriber before you stop. These are prescription-only medicines, and any decision to discontinue should involve a clinician who knows your full picture.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture this: you've just injected what you think might be your last Wegovy pen. You're not sure whether to continue, and you want to know what stopping actually feels like before you commit to the decision. The first thing most people notice is that appetite begins to return somewhere between two and four weeks after the last injection. Semaglutide's half-life sits at around seven days, so by week three or four, plasma levels have dropped to a fraction of what they were at steady state. The slowed gastric emptying that made meals feel satisfying on smaller portions gradually normalises. Food starts tasting more compelling again.
This is the point where a common misconception tends to surface: that the hunger coming back means something went wrong with the treatment, or that the medicine has somehow stopped working. It hasn't. Wegovy works while it's present in your system. The underlying biology that drove appetite before treatment is still there, and once the drug clears, it reasserts itself. That's not a failure, it's just pharmacology. Understanding it in advance makes the transition considerably less alarming.
You can read more about how quickly Wegovy's effects build and taper if you want a clearer sense of the timeline before making a final call. The NHS medicines guidance on semaglutide also outlines what to expect after stopping, and is worth reading alongside any conversation with your prescriber.
The clinical picture here is honest and worth knowing before you quit. The STEP 1 trial, published in the New England Journal of Medicine, followed participants after they stopped semaglutide 2.4mg. Within a year, most had regained roughly two-thirds of the weight they had lost. That figure is often quoted in a way that feels discouraging, but it comes with important context: the participants in the extension study had no structured behavioural support after stopping. People who have genuinely changed their eating patterns, built regular physical activity into their routine, and developed a clear understanding of their hunger cues tend to fare better.
The practical implication is that the work done during treatment (building habits, shifting what and how much feels satisfying at a meal, addressing the lifestyle factors that contributed to weight gain) is what protects you after stopping. Wegovy creates a window; what you do in that window shapes what comes after. Your prescriber can help you assess whether your current habits are robust enough to support stopping now, or whether a longer treatment period would serve you better. You might also find the Wegovy weight loss graph useful for seeing where you are in the expected trajectory before deciding.
If your reason for stopping is cost, it is worth being direct about that in your consultation, there may be options worth exploring. A summary of what Wegovy costs through a private pharmacy and what that typically includes is available separately.
There is no clinically mandated tapering protocol for semaglutide in the way there is for some other medicines. Stopping at any dose is physically safe. That said, some prescribers do recommend stepping back down through the dose schedule before stopping entirely, particularly if the current dose is 1.7mg or 2.4mg. This can smooth the return of appetite rather than making it feel abrupt. It is a conversation worth having rather than a rule to follow unilaterally.
Before your last dose, there are a few practical things to sort out. First, tell your prescriber clearly that you intend to stop and why, they may want to review your weight, your blood pressure, or any associated conditions that were being managed partly through weight loss. Second, if you are stopping because of pregnancy planning, note that the MHRA advises using effective contraception during treatment and for a period after stopping before trying to conceive; your prescriber will give you the specific timeframe. Third, if surgery is the reason, make sure your surgical team and anaesthetist know your treatment history regardless of when your last dose was.
Disposal of any remaining pens and needles should follow clinical waste guidelines. A sharps container is the correct route; standard household bins are not suitable. Finally, keep your GP informed, particularly if weight-related conditions such as high blood pressure or prediabetes were part of your clinical picture, they may want to monitor those more closely once treatment ends.
If you have been following your treatment through a structured starting process, the same prescriber who initiated your treatment is the right person to involve in the decision to stop. Our clinical team at nume reviews every repeat order individually, which means there is a natural checkpoint built in, you are never automatically continued on treatment you no longer want or need. If you have questions about stopping that you'd prefer to raise directly, our support team is available seven days a week.
For anyone considering whether to pause rather than stop completely, the distinction matters clinically. Pausing Wegovy and stopping it permanently involve slightly different considerations around re-starting eligibility, dose resets, and timing. If you are unsure which applies to your situation, that uncertainty is itself a good reason to check your eligibility and speak to a prescriber before making the call.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.